News

All 2025 pre-filled syringe doses to be made in Canada, marking a domestic production milestone CAMBRIDGE, MA / ACCESS ...
CAMBRIDGE, MA / ACCESS Newswire / July 30, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the European Commission (EC) has granted marketing authorization for the updated formulation of the ...
The approval keeps Moderna on track to deliver doses ahead of the 2025-2026 vaccination season. Production will take place in ...
Oncologists and scientists warn that extensive cuts to mRNA funding will have devastating impacts on cancer vaccine ...
Moderna has secured approval from Health Canada for Spikevax, its updated Covid-19 mRNA vaccine, which targets the SARS-CoV-2 ...
As a summer COVID-19 surge hits Michigan, unanswered questions abound about eligibility, insurance coverage and when new ...
An update to Moderna's COVID-19 vaccine that targets the newest variants and is made entirely within Canada's borders was just approved by Health Canada.
Before the pandemic, Moderna was a small, obscure outfit. In 2019, it was dependent on government agencies, non-profits, and ...
He points out that Moderna, Pfizer, and Johson &Johson are all working on second generation COVID-19 vaccines. RELATED: 'COVID arm': Some develop delayed skin reaction after Moderna vaccine shot ...
NEW YORK -- Moderna is seeking emergency use authorization from the US Food and Drug Administration for its Covid-19 vaccine for children 6 months through 5 years of age, the company said Thursday.
The Trump administration said it was terminating mRNA vaccine research and shifting focus to other approaches, including a ...
Investing.com -- Moderna Inc (NASDAQ:MRNA) stock fell 5.5% and Pfizer Inc (NYSE:PFE) shares dropped 2.6% following reports from Newsweek and The Daily Beast that the Trump administration may be ...